JP2023524547A5 - - Google Patents

Info

Publication number
JP2023524547A5
JP2023524547A5 JP2022567355A JP2022567355A JP2023524547A5 JP 2023524547 A5 JP2023524547 A5 JP 2023524547A5 JP 2022567355 A JP2022567355 A JP 2022567355A JP 2022567355 A JP2022567355 A JP 2022567355A JP 2023524547 A5 JP2023524547 A5 JP 2023524547A5
Authority
JP
Japan
Prior art keywords
salt
compound represented
structural formula
following structural
methylcyclopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022567355A
Other languages
English (en)
Japanese (ja)
Other versions
JP7643466B2 (ja
JP2023524547A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/091843 external-priority patent/WO2021223699A1/en
Publication of JP2023524547A publication Critical patent/JP2023524547A/ja
Publication of JP2023524547A5 publication Critical patent/JP2023524547A5/ja
Priority to JP2024173464A priority Critical patent/JP7643632B2/ja
Priority to JP2025029239A priority patent/JP2025081677A/ja
Application granted granted Critical
Publication of JP7643466B2 publication Critical patent/JP7643466B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022567355A 2020-05-07 2021-05-06 Kdm5阻害作用を有する3-アザビシクロ(3.1.0)ヘキサン誘導体およびその医薬用途 Active JP7643466B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024173464A JP7643632B2 (ja) 2020-05-07 2024-10-02 Kdm5阻害作用を有する3-アザビシクロ(3.1.0)ヘキサン誘導体およびその医薬用途
JP2025029239A JP2025081677A (ja) 2020-05-07 2025-02-26 Kdm5阻害作用を有する3-アザビシクロ(3.1.0)ヘキサン誘導体およびその医薬用途

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2020/088925 2020-05-07
CN2020088925 2020-05-07
PCT/CN2021/091843 WO2021223699A1 (en) 2020-05-07 2021-05-06 3-azabicyclo(3.1.0)hexane derivatives having kdm5 inhibitory activity and use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024173464A Division JP7643632B2 (ja) 2020-05-07 2024-10-02 Kdm5阻害作用を有する3-アザビシクロ(3.1.0)ヘキサン誘導体およびその医薬用途

Publications (3)

Publication Number Publication Date
JP2023524547A JP2023524547A (ja) 2023-06-12
JP2023524547A5 true JP2023524547A5 (cg-RX-API-DMAC7.html) 2024-04-17
JP7643466B2 JP7643466B2 (ja) 2025-03-11

Family

ID=76159223

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2022567355A Active JP7643466B2 (ja) 2020-05-07 2021-05-06 Kdm5阻害作用を有する3-アザビシクロ(3.1.0)ヘキサン誘導体およびその医薬用途
JP2024173464A Active JP7643632B2 (ja) 2020-05-07 2024-10-02 Kdm5阻害作用を有する3-アザビシクロ(3.1.0)ヘキサン誘導体およびその医薬用途
JP2025029239A Withdrawn JP2025081677A (ja) 2020-05-07 2025-02-26 Kdm5阻害作用を有する3-アザビシクロ(3.1.0)ヘキサン誘導体およびその医薬用途

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024173464A Active JP7643632B2 (ja) 2020-05-07 2024-10-02 Kdm5阻害作用を有する3-アザビシクロ(3.1.0)ヘキサン誘導体およびその医薬用途
JP2025029239A Withdrawn JP2025081677A (ja) 2020-05-07 2025-02-26 Kdm5阻害作用を有する3-アザビシクロ(3.1.0)ヘキサン誘導体およびその医薬用途

Country Status (13)

Country Link
US (3) US11691968B2 (cg-RX-API-DMAC7.html)
EP (2) EP4471027A1 (cg-RX-API-DMAC7.html)
JP (3) JP7643466B2 (cg-RX-API-DMAC7.html)
KR (2) KR102937044B1 (cg-RX-API-DMAC7.html)
CN (1) CN115461338B (cg-RX-API-DMAC7.html)
AU (1) AU2021268223C1 (cg-RX-API-DMAC7.html)
BR (1) BR112022022005A2 (cg-RX-API-DMAC7.html)
CA (1) CA3181604A1 (cg-RX-API-DMAC7.html)
ES (1) ES3037418T3 (cg-RX-API-DMAC7.html)
IL (1) IL297900B2 (cg-RX-API-DMAC7.html)
MX (1) MX2022013692A (cg-RX-API-DMAC7.html)
TW (1) TWI895412B (cg-RX-API-DMAC7.html)
WO (1) WO2021223699A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3999183A4 (en) * 2019-07-17 2023-11-15 Ono Pharmaceutical Co., Ltd. COMPOUNDS HAVING KDM5 INHIBITANT ACTION AND THEIR PHARMACEUTICAL USES
AU2021268223C1 (en) 2020-05-07 2026-07-09 Ono Pharmaceutical Co., Ltd. Compound having KDM5 inhibitory activity and pharmaceutical use thereof
JP2023070165A (ja) * 2021-11-05 2023-05-18 小野薬品工業株式会社 アザビシクロ環化合物の結晶
JP7743829B2 (ja) * 2021-11-05 2025-09-25 小野薬品工業株式会社 Kdm5阻害作用を有する化合物を含有する医薬組成物
TW202612686A (zh) * 2024-05-17 2026-04-01 日商小野藥品工業股份有限公司 失智症之行動及心理症狀之預防、進展抑制及/或治療劑

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI244481B (en) 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
GB0311859D0 (en) 2003-05-22 2003-06-25 Merck Sharp & Dohme Therapeutic agents
EP1765379A4 (en) 2004-06-17 2009-05-27 Transform Pharmaceuticals Inc PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS AND RELEVANT USE METHOD
JP2008524331A (ja) 2004-12-21 2008-07-10 武田薬品工業株式会社 ジペプチジルペプチダーゼ阻害剤
WO2009047161A1 (en) 2007-10-09 2009-04-16 F. Hoffmann-La Roche Ag Chiral cis-imidazolines
EP3204379B1 (en) * 2014-10-10 2019-03-06 Genentech, Inc. Pyrrolidine amide compounds as histone demethylase inhibitors
CN108341819B (zh) 2017-01-22 2021-06-15 南京药捷安康生物科技有限公司 磷酸二酯酶抑制剂及其用途
EP3999183A4 (en) 2019-07-17 2023-11-15 Ono Pharmaceutical Co., Ltd. COMPOUNDS HAVING KDM5 INHIBITANT ACTION AND THEIR PHARMACEUTICAL USES
AU2021268223C1 (en) 2020-05-07 2026-07-09 Ono Pharmaceutical Co., Ltd. Compound having KDM5 inhibitory activity and pharmaceutical use thereof

Similar Documents

Publication Publication Date Title
JPWO2021220648A5 (cg-RX-API-DMAC7.html)
JP2018024670A5 (cg-RX-API-DMAC7.html)
JP2010501534A5 (cg-RX-API-DMAC7.html)
JP2006526031A5 (cg-RX-API-DMAC7.html)
JP2016153424A5 (cg-RX-API-DMAC7.html)
JPWO2022014680A5 (cg-RX-API-DMAC7.html)
JP2009215321A5 (cg-RX-API-DMAC7.html)
JP2009535462A5 (cg-RX-API-DMAC7.html)
JP2018024682A5 (cg-RX-API-DMAC7.html)
JP2008506632A5 (cg-RX-API-DMAC7.html)
JP2010507641A5 (cg-RX-API-DMAC7.html)
JP2010536766A5 (cg-RX-API-DMAC7.html)
JP2022540353A5 (cg-RX-API-DMAC7.html)
JP2015199738A5 (cg-RX-API-DMAC7.html)
JP2013532130A5 (cg-RX-API-DMAC7.html)
JP2020504434A5 (cg-RX-API-DMAC7.html)
JP2025111617A5 (cg-RX-API-DMAC7.html)
JP2015510508A5 (cg-RX-API-DMAC7.html)
CN114206850A (zh) 作为crac抑制剂的2h-苯并吡喃衍生物
JP2017521375A5 (cg-RX-API-DMAC7.html)
JP2015044837A5 (cg-RX-API-DMAC7.html)
JP2011016798A5 (cg-RX-API-DMAC7.html)
JP2023508938A5 (cg-RX-API-DMAC7.html)
JP2020529598A5 (cg-RX-API-DMAC7.html)
JP2007532575A5 (cg-RX-API-DMAC7.html)